YBGJYubo International Biotech Limited

About Yubo International Biotech Limited (YBGJ)

Yubo International Biotech Limited (YBGJ) is a Medical Instruments & Supplies company headquartered in Beijing, China whose shares trade over-the-counter on the OTCQB tier.

Yubo International Biotech Limited (together with its subsidiaries, "Yubo") is a U.S. holding company. Through its wholly-owned subsidiaries, and certain contractual arrangements with a PRC entity, Yubo provides research and development and application of endometrial stem cells. Yubo is committed to building the first public endometrial stem cell repository in the world. Yubo offers its products and services under the brand "VIVCELL". Yubo's product offerings include healthcare products for respiratory system, skincare products, hair care products, healthy beverages and male and female personal care products. Yubo also offers stem cell related services including cell testing and health management consulting services.

Products and services

The Company primarily engages in the research, development and application of endometrial stem cell (including related services such as cell testing and health management consulting services) and the sale and distribution of healthcare products for respiratory system, skincare products, hair care products, healthy beverages and male and female personal care products.

YBGJ key facts

Ticker symbol

YBGJ

Market tier

OTCQB

Sector

Healthcare

Industry

Medical Instruments & Supplies

Headquarters

Beijing, China

Country of incorporation

US

Year of incorporation

1991

Employees

18

Estimated market cap

$6.35M (as of Apr 10, 2025)

Shares outstanding

119,816,343

Reporting standard

U.S. Reporting: SEC Reporting

Audit status

Audited

Fiscal year end

12/31

Yubo International Biotech Limited leadership

• Jun Wang — CEO, President
• Lina Liu — CFO, Treasurer, Company Secretary

Explore more: Medical Instruments & Supplies stocks · Healthcare sector · OTCQB stocks · OTC stocks starting with Y